Insta Cath Conference (6)
25 Jan 2022
Contributed by Lukas
Expert discussion on complex and interesting angiograms
Insta Cath Conference (1)
25 Jan 2022
Contributed by Lukas
Expert discussion on complex and interesting angiograms
Case Discussion (6)
25 Jan 2022
Contributed by Lukas
Anticoagulation in AF & MR A Concise Case Based Discussion
HeartCast 2: practical approach to the treatment of HFrEF
25 Jan 2022
Contributed by Lukas
The second HeartCast: HFrEF management
HeartCast 3: practical approach to the treatment of HFrEF
25 Jan 2022
Contributed by Lukas
The third HeartCast: HFrEF management
At a Glance: Approach to Ticagrelor-induced Dyspnea
25 Jan 2022
Contributed by Lukas
Managing dyspnea induced by Ticagrelor
At a glance: preventing cardiovascular thrombotic event after ACS
25 Jan 2022
Contributed by Lukas
Ticagrelor in preventing post-ACS thrombotic events
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
25 Jan 2022
Contributed by Lukas
Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
Cardiopoint (12): Two-Drug Combinations as First-Step Antihypertensive treatment
25 Jan 2022
Contributed by Lukas
Initial administration of two-drug combinations in HTN
HeartCast 1: practical approach to the treatment of HFrEF
25 Jan 2022
Contributed by Lukas
The first HeartCast: HFrEF management
Self-measured blood pressure monitoring at home
25 Jan 2022
Contributed by Lukas
What to teach the patients about recording their blood pressure themselves
CardioPoint (10): The growing burden of cardiovascular diseases
25 Jan 2022
Contributed by Lukas
Emphasizing the importance of CVD prevention and management
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
25 Jan 2022
Contributed by Lukas
Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
25 Jan 2022
Contributed by Lukas
Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
25 Jan 2022
Contributed by Lukas
Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
Cardiopoint (13): Management of stage 1 hypertension in adults with low cardiovascular risk
25 Jan 2022
Contributed by Lukas
Stage 1 HTN in low risk patients
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part one: Eplerenone in the pipeline
25 Jan 2022
Contributed by Lukas
Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
Apixaban Hub (4)
25 Jan 2022
Contributed by Lukas
NOAC Choice
CardioPoint (1): Statins-Who is eligible?-Which dose?
18 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Cardiometabolic Field
Guideline Made Easy (5)
18 Jan 2022
Contributed by Lukas
Practical Guide for treatment of high blood cholesterol Part Two
CardioPoint (3): NOACs in Elderly
18 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Anticoagulation
CardioPoint (2): NOAC Monitoring, Do NOACs Need Monitoring?
18 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Anticoagulation
PCSK9 Inhibition from bench to bedside (4)
17 Jan 2022
Contributed by Lukas
Part Four: The Lower, The Better
PCSK9 Inhibition from bench to bedside (1)
17 Jan 2022
Contributed by Lukas
Part One: A success story
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Cardiometabolic Field
Guideline Made Easy (1)
17 Jan 2022
Contributed by Lukas
Practical Guide for Treatment of High Blood Pressure (Part One)
Apixaban Hub (1)
17 Jan 2022
Contributed by Lukas
When to use, when not to use & which dose?
Guideline Made Easy (4)
17 Jan 2022
Contributed by Lukas
Practical Guide for treatment of high blood cholesterol Part One
Apixaban Hub (2)
17 Jan 2022
Contributed by Lukas
Apixaban in the pipeline: landmark clinical trials
At a glance: ACEI and ARB in COVID-19 Era
17 Jan 2022
Contributed by Lukas
The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
At a glance; How dual pathway found its way into ESC guidelines?
17 Jan 2022
Contributed by Lukas
Rivaroxaban on board for CCS
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
17 Jan 2022
Contributed by Lukas
Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
PCSK9 Inhibition from bench to bedside (2)
17 Jan 2022
Contributed by Lukas
Part Two: Clinical Trials
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Cardiometabolic Field
At a glance; FDC role in HTN Pharmacotherapy
17 Jan 2022
Contributed by Lukas
Fixed dose combination therapy in HTN Treatment
CardioPoint (8): When to consider drug treatment in hypertension?
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Cardiometabolic Field
Cardiac involvement in COVID-19 infection
17 Jan 2022
Contributed by Lukas
Cardiovascular complications of COVID-19
Guideline Made Easy (3)
17 Jan 2022
Contributed by Lukas
Practical Guide for Treatment of High Blood Pressure (Part Three)
Apixaban Hub (3)
17 Jan 2022
Contributed by Lukas
Apixaban in Clinical Practice
PCSK9 Inhibition from bench to bedside (3)
17 Jan 2022
Contributed by Lukas
Part Three: PCSK9 Inhibitor in my practice
CardioPoint (5): NOACs in CKD
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Anticoagulation
At a glance; Place of FDC in CV outcomes
17 Jan 2022
Contributed by Lukas
Single-Pill Combination Therapy and CV Outcomes in HTN
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Anticoagulation
CardioPoint (7): Selecting appropriate NOAC
17 Jan 2022
Contributed by Lukas
A Brief Description on Practical Points in Anticoagulation
Guideline Made Easy (2)
17 Jan 2022
Contributed by Lukas
Practical Guide for Treatment of High Blood Pressure (Part Two)
Guideline Made Easy (6)
17 Jan 2022
Contributed by Lukas
Practical Guide for treatment of high blood cholesterol Part Three
DiaBeat: The Beating Heart of Diabetes (4th session)
15 Jan 2022
Contributed by Lukas
4th Diabetes Masterclass for Cardiologists
DiaBeat: The Beating Heart of Diabetes (3rd session)
15 Jan 2022
Contributed by Lukas
3rd Diabetes Masterclass for Cardiologists
DiaBeat: The Beating Heart of Diabetes (5th session)
15 Jan 2022
Contributed by Lukas
5th Diabetes Masterclass for Cardiologists
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
15 Jan 2022
Contributed by Lukas
Rivaroxaban vs Apixaban in AF
Antiplatelet journal scan
15 Jan 2022
Contributed by Lukas
A review on recent antiplatelet therapy trials
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
15 Jan 2022
Contributed by Lukas
The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
Landmark trials of ESC 2021 congress
15 Jan 2022
Contributed by Lukas
2021 post-ESC headlines
Cardio-Watch Podcast: Episode 4, Dyslipidemia
15 Jan 2022
Contributed by Lukas
The fourth episode of Cardio-Watch: Dyslipidemia
Cardio-Watch Podcast: Episode 7, ESC 2021 special
15 Jan 2022
Contributed by Lukas
The seventh episode of Cardio-Watch: ESC 2021
Impact: Statin treatment and muscle symptoms
15 Jan 2022
Contributed by Lukas
StatinWise Trial
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
15 Jan 2022
Contributed by Lukas
Diagnosis and management of Iron deficiency in HF patients
Cardio-Watch podcast: Episode 2, Hypertension
15 Jan 2022
Contributed by Lukas
The second episode of Cardio-Watch: Hypertension
Impact: DAPT vs. Aspirin in patients with stroke or TIA
15 Jan 2022
Contributed by Lukas
A recent meta-analysis about antiplatelet therapy in stroke
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
15 Jan 2022
Contributed by Lukas
The role of Heparin in the management of thrombosis in COVID-19
Cardio-Watch Podcast: Episode 6, Electrophysiology
15 Jan 2022
Contributed by Lukas
The sixth episode of Cardio-Watch: Electrophysiology
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
15 Jan 2022
Contributed by Lukas
Neprilysin Inhibitors to prevent LV remodeling post MI
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
15 Jan 2022
Contributed by Lukas
The Third episode of Cardio-Watch: AF
A review on four landmark anti-platelet therapy trials
15 Jan 2022
Contributed by Lukas
The latest updates on anti-platelet therapy from 4 important trials
Left Atrial Appendage Occlusion to prevent Stroke
15 Jan 2022
Contributed by Lukas
Preventing Stroke by surgical LA Appendage Occlusion
Cardio-Watch Podcast: Episode 1, COVID-19 and the heart
15 Jan 2022
Contributed by Lukas
The first episode of Cardio-Watch podcast
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
15 Jan 2022
Contributed by Lukas
The fifth episode of Cardio-Watch: cardiometabolic disorders
Impact: the paradox of physical activity in cardiovascular disease
15 Jan 2022
Contributed by Lukas
The contemporary Copenhagen general population study
Impact: No-LVT trial
15 Jan 2022
Contributed by Lukas
Comparative study of oral anticoagulation in left ventricular thrombi
Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial
15 Jan 2022
Contributed by Lukas
Midodrine in vasovagal syndrome prevention
Safety and Efficacy of different antithrombotic strategies after TAVI
15 Jan 2022
Contributed by Lukas
Post-TAVI antithrombotic strategies
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
15 Jan 2022
Contributed by Lukas
Impact of Dapagliflozin on the survival of HFrEF patients
Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial
15 Jan 2022
Contributed by Lukas
Milrinone vs. Dobutamine: DOREMI trial
Dapagliflozin in non-DM Patients with HF and Reduced EF
15 Jan 2022
Contributed by Lukas
The findings of DAPA-HF trial in non-diabetics
Benefits of Targeting for a
15 Jan 2022
Contributed by Lukas
The findings of TST study
Electrical versus pharmacological cardioversion for acute AF in emergency settings
15 Jan 2022
Contributed by Lukas
The findings of RAFF2 trial
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
15 Jan 2022
Contributed by Lukas
Monthly Case-Based Clinical Problem Solving
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
15 Jan 2022
Contributed by Lukas
Insights from DECLARE-TIMI 58 Trial
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
15 Jan 2022
Contributed by Lukas
Monthly Case-Based Clinical Problem Solving
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
15 Jan 2022
Contributed by Lukas
Monthly Case-Based Clinical Problem Solving
Predicting the Risk of Post-stroke Atrial Cardiopathy
15 Jan 2022
Contributed by Lukas
An interim analysis from ACARDIA trial
Intensive LDL lowering beyond current recommendations for MACE prevention
15 Jan 2022
Contributed by Lukas
A meta-analysis of RCTs
Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
15 Jan 2022
Contributed by Lukas
Monthly Case-Based Clinical Problem Solving
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
15 Jan 2022
Contributed by Lukas
A meta-analysis of RCTs
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
15 Jan 2022
Contributed by Lukas
The findings of a recent study
Intensive Blood Pressure lowering and the Concerns about Falling
15 Jan 2022
Contributed by Lukas
The findings of SPRINT trial
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
15 Jan 2022
Contributed by Lukas
Monthly Case-Based Clinical Problem Solving
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
15 Jan 2022
Contributed by Lukas
A meta-analysis of RCTs
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
15 Jan 2022
Contributed by Lukas
The renal and cardiovascular protective effects of SGLT2 inhibitors
Timing of Staged Non-Culprit Artery PCI in STEMI
15 Jan 2022
Contributed by Lukas
The findings of COMPLETE Trial about PCI timing
Inclisiran for patients with ASCVD and elevated LDL
15 Jan 2022
Contributed by Lukas
The findings of ORION-10 trial in ASCVD patients
The Efficacy and Safety of Low-Dose Colchicine after MI
15 Jan 2022
Contributed by Lukas
The findings of COLCOT trial about colchicine post-MI
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
15 Jan 2022
Contributed by Lukas
The findings of ISCHEMIA trial
Antithrombotic treatment after CABG
15 Jan 2022
Contributed by Lukas
A recent meta-analysis on post-CABG Antithrombotic therapy
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
15 Jan 2022
Contributed by Lukas
The findings of RECOVERY trial
AF after Non-Cardiac Surgery Increases the Risk of Stroke
15 Jan 2022
Contributed by Lukas
A meta-analysis of post-operative AF studies
Triglyceride Lowering and Cardiovascular Risk Reduction
15 Jan 2022
Contributed by Lukas
A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
15 Jan 2022
Contributed by Lukas
The findings of ORION-9 trial about Inclisiran in HeFH
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
15 Jan 2022
Contributed by Lukas
Rivaroxaban versus warfarin in APS
Ticagrelor with or without Aspirin in High-Risk patients after PCI
15 Jan 2022
Contributed by Lukas
The findings of TWILIGHT Trial